Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone versus sufentanil for analgesia in mechanically ventilated ICU patients
ChiCTR2500103498Phase 4Not yet recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- May 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in pain comparing Hydromorphone group with Sufentanil group (2 arms). Primary endpoint: Proportion of patients with satisfactory analgesia during the study period. Planned start May 2025; status: not yet recruiting.
02
Drugs
hydromorphonesufentanil
03
Conditions
pain
Beyond the preview
Go deeper on ChiCTR2500103498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103498.